The estimated Net Worth of David Matthew Stark is at least $2.04 millió dollars as of 6 March 2023. Mr. Stark owns over 65,966 units of Teva- Pharmaceutical Industries stock worth over $53,413 and over the last 7 years he sold TEVA stock worth over $1,984,578. In addition, he makes $0 as Executive Vice President és Chief Legal Officer at Teva- Pharmaceutical Industries.
David has made over 15 trades of the Teva- Pharmaceutical Industries stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 65,966 units of TEVA stock worth $629,975 on 6 March 2023.
The largest trade he's ever made was exercising 72,068 units of Teva- Pharmaceutical Industries stock on 4 March 2022 worth over $1,294,341. On average, David trades about 21,116 units every 45 days since 2018. As of 6 March 2023 he still owns at least 2,974 units of Teva- Pharmaceutical Industries stock.
You can see the complete history of Mr. Stark stock trades at the bottom of the page.
David Matthew Stark serves as Executive Vice President, Chief Legal Officer of the Company. He served as Group Executive Vice President, Chief Legal Officer. From 2014 to 2015, Mr. Stark was Senior Vice President and General Counsel, Global Specialty Medicines. Since joining Teva in 2002, Mr. Stark served in a series of roles with increasing responsibilities in Teva North America and Teva Americas, including as Senior Director, Deputy General Counsel, and Vice President and General Counsel. Prior to joining Teva, Mr. Stark was an associate attorney in the litigation departments at Willkie Farr & Gallagher LLP between 1998 and 2002, Chadbourne & Parke between 1997 and 1998 and Haight, Gardner, Poor & Havens between 1994 and 1997.
David Stark is 51, he's been the Executive Vice President és Chief Legal Officer of Teva- Pharmaceutical Industries since 2016. There are 20 older and 7 younger executives at Teva- Pharmaceutical Industries. The oldest executive at Teva- Pharmaceutical Industries Ltd. is Gerald Lieberman, 73, who is the Independent Director.
David's mailing address filed with the SEC is C/O TEVA PHARMACEUTICAL INDUSTRIES LTD., 124 DVORA HANEVI'A ST.,, TEL AVIV, L3, 6944020.
Over the last 7 years, insiders at Teva- Pharmaceutical Industries have traded over $31,332,399 worth of Teva- Pharmaceutical Industries stock and bought 967,500 units worth $16,473,820 . The most active insiders traders include Sol J Barer, Tal Zvi Zaks és Roberto Mignone. On average, Teva- Pharmaceutical Industries executives and independent directors trade stock every 9 days with the average trade being worth of $636,538. The most recent stock trade was executed by Varda Shalev on 2 September 2024, trading 12,872 units of TEVA stock currently worth $231,181.
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals.
Teva- Pharmaceutical Industries executives and other stock owners filed with the SEC include: